| Drug Name |
Pasireotide |
| Drug ID |
BADD_D01684 |
| Description |
Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor, which is used in the treatment of Cushing's disease. |
| Indications and Usage |
For the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery has not been curative or is not an option. |
| Marketing Status |
Not Available |
| ATC Code |
H01CB05 |
| DrugBank ID |
DB06663
|
| KEGG ID |
D10147
|
| MeSH ID |
C517782
|
| PubChem ID |
9941444
|
| TTD Drug ID |
D0TV0C
|
| NDC Product Code |
0078-0634; 71161-126; 0078-0643; 55292-143; 71161-130; 55292-142; 55292-139; 0078-0642; 0078-0741; 55292-141; 55292-132; 0078-0633; 0078-0748; 55292-140; 55292-131; 71161-129; 55292-133; 0078-0635; 0078-0641; 71161-127; 71161-128 |
| Synonyms |
pasireotide | cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-d-tryptophyl-L-lysyl-4-o-benzyl-L-tyrosyl-L-phenylalanyl-) | SOM-230 | SOM 230 | SOM230 |
